Form 8-K - Current report:
SEC Accession No. 0001213900-25-016309
Filing Date
2025-02-24
Accepted
2025-02-24 08:00:20
Documents
13
Period of Report
2025-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0231832-8k_ispecimen.htm   iXBRL 8-K 25914
  Complete submission text file 0001213900-25-016309.txt   200120

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ispc-20250219.xsd EX-101.SCH 3018
3 XBRL LABEL FILE ispc-20250219_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ispc-20250219_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0231832-8k_ispecimen_htm.xml XML 3672
Mailing Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101
Business Address 8 CABOT ROAD SUITE 1800 WOBURN MA 08101 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40501 | Film No.: 25654269
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)